Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 201–250 of 76231
Mr. Casaccia will replace Mr. Jordan Krugman, who, as previously disclosed, gave notice of his resignation from the Board of Managers of the Managing Owner as of the Effective Date.
Mr. Casaccia will replace Mr. Jordan Krugman, who, as previously disclosed, gave notice of his resignation from the Board of Managers of the Sponsor as of the Effective Date.
Effective August 3, 2026, the Company accepted the resignation of Alexander M. Woods-Leo from all of his positions with the Company, including President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and Director.
On July 31, 2026, the Board of Directors (the “Board”) of Amaze Holdings, Inc. (the “Company”) determined that Aaron Day would no longer serve as Chief Executive Officer of the Company, effective immediately.
On July 31, 2026, Research Solutions, Inc. terminated Sefton Cohen from the position of Chief Revenue Officer.
the retirement of Wm. Gordon Prescott as General Counsel and Corporate Secretary effective as of July 31, 2026.
each of Dirk Thye, the Chief Executive Officer and Chief Medical Officer of Quince Therapeutics, Inc. (the “ Company ”), and a member of the Company’s board of directors (the “ Board ”), and Brendan Hannah, the Company’s Chief Operating Officer, Chief Business Officer and Chief Compliance Officer, tendered conditional resignations from their positions with the Company
each of Dirk Thye, the Chief Executive Officer and Chief Medical Officer of Quince Therapeutics, Inc. (the “ Company ”), and a member of the Company’s board of directors (the “ Board ”), and Brendan Hannah, the Company’s Chief Operating Officer, Chief Business Officer and Chief Compliance Officer, tendered conditional resignations from their positions with the Company
On July 31, 2026, CarMax, Inc. (the “Company”) announced that Diane Cafritz, the Company’s Executive Vice President and Chief Innovation and People Officer, will be leaving the Company effective December 31, 2026.
On July 30, 2026, Professor Amnon Peled notified the Board of Directors (the “ Board ”) of Silexion Therapeutics Corp (the “ Company ”) of his resignation from his position as a member of the Board, for personal reasons, effective as of August 1, 2026.
Mr. Stiles gave official notice of his resignation on July 30, 2026, with an effective date of August 31, 2026 (the " Resignation ").
On July 29, 2026, Daniel Kasell notified Diameter Credit Company (the “Company”) of his decision to resign from the Board of Trustees of the Company (the “Board”) and all committees thereof, effective immediately.
On July 30, 2026, N.A. (Neil) Hansen announced his intention to step down from the board. Effective July 30, 2026, Mr. Hansen resigned from his position as director and member of the board’s finance committee and safety and sustainability committee.
On July 27, 2026, the Board of Directors (the “Board”) of Wabash National Corporation (the “Company”) accepted the resignation of Sudhanshu Priyadarshi as a director of the Company with the acceptance of such resignation to be effective on August 1, 2026 (the “Resignation”).
On July 24, 2026, Mr. Martin Petraitis, Vice President of Sales and a named executive officer of Cyngn Inc. (the “Company”), was terminated from his position with the Company, effective the same date.
On July 25, 2026, Mr. Chris Drumgoole notified DXC Technology Company (the “Company”) of his decision to resign as President, Global Infrastructure Services, effective July 30, 2026.
On July 28, 2026, Herbert W. Moloney III informed the Board of Directors (the “Board”) of Lee Enterprises, Incorporated (the “Company”) he is retiring from the Board effective July 28, 2026.
On July 28, 2026, our board of directors elected Tobias B. Moss as a member of the board of directors, effective July 28, 2026, to replace Belvin Williamson, Jr.
On July 24, 2026, Sean D. Keohane of Cabot Corporation (the “Company”) notified the Company’s Board of Directors (the “Board”) of his decision to retire as President and Chief Executive Officer and resign as a Director of the Company and a member of the Board’s Executive Committee, each effective September 30, 2026.
On July 28, 2026, Bertrand Loy, Executive Chair of the Board of Directors (the "Board") of Entegris, Inc. (the "Company"), notified the Board that he will retire from his employment with the Company as Executive Chair effective July 31, 2026 upon the expiration of the Executive Chair Agreement
On July 29, 2026, Isabelle Courville, Chair of the Board of Directors (the “Board”) of Canadian Pacific Kansas City Limited (the “Company”), notified the Company of her decision to retire from the Board, effective immediately.
certain officers of the Company, including John E. Sagartz (Chief Strategy Officer) and Adrian P. Hardy (Chief Commercial Officer), resigned as officers of the Company on the Plan Effective Date.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
certain officers of the Company, including John E. Sagartz (Chief Strategy Officer) and Adrian P. Hardy (Chief Commercial Officer), resigned as officers of the Company on the Plan Effective Date.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
each of John Sagartz, R. Matthew Neff, David Landman, Terry Coelho, Robert W. Leasure Jr., Michael Harrington, Nigel Brown, Eugene Davis, and John T. Young Jr. resigned from the board of directors of the Company.
On July 29, 2026, The Procter & Gamble Company (the "Company") announced that Jon R. Moeller, Executive Chairman of the Board, will retire from his position as Executive Chairman and as a member of the Board of Directors (“the Board”), effective July 31, 2026.
Effective July 24, 2026, the Board of Directors accepted the resignation of Daniel Snyder as a Director of the Issuer pursuant to his retirement request, effective immediately.
each of David Domzalski, VYNE’s President and Chief Executive Officer, Iain Stuart, Ph.D., VYNE’s Chief Scientific Officer, and Mutya Harsch, VYNE’s Chief Legal Officer and General Counsel, resigned as executive officers at the Closing and their employment was terminated effective July 27, 2026
each of David Domzalski, VYNE’s President and Chief Executive Officer, Iain Stuart, Ph.D., VYNE’s Chief Scientific Officer, and Mutya Harsch, VYNE’s Chief Legal Officer and General Counsel, resigned as executive officers at the Closing and their employment was terminated effective July 27, 2026
each of David Domzalski, VYNE’s President and Chief Executive Officer, Iain Stuart, Ph.D., VYNE’s Chief Scientific Officer, and Mutya Harsch, VYNE’s Chief Legal Officer and General Counsel, resigned as executive officers at the Closing and their employment was terminated effective July 27, 2026
on July 22, 2026, Mr. Dunn notified the Company that his resignation as CFO will be effective August 21, 2026
Each of Haya Taitel and Yonatan Malca has communicated to the Board that he or she will either resign from the Board or not stand for reelection to the Board, in either case, effective upon the date that a corresponding New Independent Director is appointed or elected to the Board.
Each of Haya Taitel and Yonatan Malca has communicated to the Board that he or she will either resign from the Board or not stand for reelection to the Board, in either case, effective upon the date that a corresponding New Independent Director is appointed or elected to the Board.
On July 22, 2026, TransparentBusiness, Inc., (the “Company”) received notice that Andrew Winn resigned from his position as Chief Financial Officer, effective August 4, 2026, due to personal reasons.
Mogens C. Bay informed the Board of Directors (the “Board”) of Valmont Industries, Inc. (the “Company”) of his decision to retire from the Board at the end of the Company’s fiscal year, December 26, 2026.
removed Dr. Kenneth L. Perego, II from the Company’s Board of Directors (the “Board”), effective immediately.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
after which Ms. Rosenfeld resigned as Trustee of the Company and the Board reduced its size to five members.
Julie Masino, the Company’s President and Chief Executive Officer, will step down from that role effective August 10, 2026
Ms. Masino will resign from the Board on the Effective Date
Mr. Ingram will depart from his position as Chief Executive Officer and a member of the Board as of the Effective Date.
Mr. Ingram will depart from his position as Chief Executive Officer and a member of the Board as of the Effective Date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.